An over-the-counter brand of the drug modafinil is called Modalert. The majority of the 100 and 200 mg pills produced by Sun Pharmaceuticals are produced in India and distributed via online pharmacies.

All users of this wakefulness-promoting medicine have become more familiar with Modalert 200 as a result of the high cost of Provigil, the most widely used generic form of Modafinil.

Modalert is usually included within the well-known nootropics subclass. Because it aims to improve memory, learning, and other cognitive processes, it is also known as a drug chip or cognitive enhancer.

Modalert 200 mg was initially created to help people with sleep disorders like narcolepsy and sleep apnea increase their alertness, wakefulness, and attentiveness. It is also known to enhance mental capacity, focus, and attention.

There was also a plan to make Modafinil for treating ADHD legal. In the end, the FDA reached the highly contested conclusion that the medication was appropriate for treating the symptoms of ADHD in children. In comparison to Ritalin and Adderall, Sun Pharma Modalert is thought to have a lower risk of negative side effects, addiction, and withdrawal.

History of Modafinil

Consider learning about Modafinil's history before you buy it. The late 1970s saw the development of modafinil in France as an adrafinil derivative. Adrafinil and numerous other sulfinylbenzhydryl compounds were discovered in 1974. Adrafinil was first used as a treatment for narcolepsy sleep problems in France in 1986 after extensive research on the drug.

During the experiment to look into the mechanism of action of Adrafinil, Modafinil was found. It was shown that adrafinil was converted in the body into the inactive component modafinil acid and the active molecule modafinil.

Modafinil could now be produced directly by scientists after more testing and development. Although the effects of modafinil and its parent substance, adrafinil, are roughly the same, modafinil is currently far more well-known than adrafinil due to its vastly increased potency and speed.

Like its precursor medicine, Adrafinil, modafinil was initially tested on humans for narcolepsy. A sleep-wake disorder called narcolepsy is characterized by severe daytime sleepiness, possibly inadequate nocturnal sleep, difficulty staying awake during the day, and irregular daily naps.

Modafinil has been shown to be much more effective than placebo at improving wakefulness and decreasing daytime sleepiness in narcolepsy patients in numerous double-blind, placebo-controlled studies. The FDA approved modafinil as a narcolepsy treatment in the US in 1998.

Similar to shift work sleep disorder, obstructive apnea/hypopnea syndrome, and other sleep disorders characterized by excessive sleepiness, modafinil has been the focus of substantial investigation.